|
PGM2L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00830000000041E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.14869999999312E-05 |
| Normal-vs-Stage2 |
3.139000E-01 |
| Normal-vs-Stage3 |
8.577300E-04 |
| Normal-vs-Stage4 |
1.775060E-03 |
| Stage1-vs-Stage2 |
1.113850E-02 |
| Stage1-vs-Stage3 |
5.300400E-01 |
| Stage1-vs-Stage4 |
5.915600E-01 |
| Stage2-vs-Stage3 |
6.621700E-02 |
| Stage2-vs-Stage4 |
2.660000E-02 |
| Stage3-vs-Stage4 |
3.702200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97759999998048E-06 |
| Normal-vs-AfricanAmerican |
2.705700E-02 |
| Normal-vs-Asian |
1.664500E-02 |
| Caucasian-vs-AfricanAmerican |
6.929600E-01 |
| Caucasian-vs-Asian |
8.755800E-01 |
| AfricanAmerican-vs-Asian |
8.754600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.049600E-04 |
| Normal-vs-Female |
4.2914000000005E-05 |
| Male-vs-Female |
8.558400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.84099999981314E-07 |
| Normal-vs-Age(41-60Yrs) |
2.261700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.328100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.324210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.897400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.264200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.498600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.258400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.951800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.987200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.175600E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
7.702200E-01 |
| Classical-VS-Normal |
1.13600000517522E-08 |
| Tall-VS-Follicular |
1.33440003491359E-09 |
| Tall-VS-Other |
8.985800E-01 |
| Tall-VS-Normal |
1.234610E-04 |
| Follicular-VS-Other |
6.270200E-02 |
| Follicular-VS-Normal |
6.804300E-02 |
| Other-VS-Normal |
4.444100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.070300E-02 |
| Normal-vs-N1 |
7.359800E-04 |
| N0-vs-N1 |
1.274430E-02 |
|
|
